Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura
Clinical trial NCT00486421 · COMPLETED
Trial details
- NCT number
- NCT00486421
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-05-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.